#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neuroendocrine tumour Thymic carcinoma Ureteric cancer Encephalopathy neonatal Ventricular fibrillation Acute myeloid leukaemia (in remission) Mantle cell lymphoma stage III Soft tissue sarcoma Eosinophilic granulomatosis with polyangiitis T-cell lymphoma Sarcoma Cutaneous T-cell lymphoma stage I Chronic cutaneous lupus erythematosus Von Hippel-Lindau disease Pleural mesothelioma malignant More trials…

    Learn about Rare Diseases

    Lysosomal storage disorder Rhabdomyosarcoma recurrent – Trials in Disease Mantle cell lymphoma stage IV – Basic Information Pemphigoid – Treatment Bronchopulmonary dysplasia – Trials in Disease Arterial tortuosity syndrome – Basic Information Nephroblastoma – Trials in Disease Antisynthetase syndrome – Diagnostics Undifferentiated sarcoma Wolfram syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ilofotase Alfa Peposertib Gemtuzumab Ozogamicin Cenerimod Mavorixafor Gallium Citrate Ga-68 Calcium Lactate Gluconate Metronidazole IDP-121 Ethanol, Anhydrous Toldc Nilotinib INCB123667 Tolcapone Cefixime Trihydrate Bilastine Lymecycline DROSPIRENONE Alizapride Empagliflozin More therapies…

    Learn about Your Condition

    Neonatal hyperglycaemia Biliary adenoma Synovial sarcoma Becker's muscular dystrophy Genital herpes simplex Vestibular disorder Iron deficiency anaemia Giant cell arteritis Tinnitus Facial paresis Anorexia nervosa Infantile spasms Hypothyroidism Medication overuse headache Chronic spontaneous urticaria More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Immunodeficiency common variable

  • A Study of Leniolisib Safety and Effectiveness for Immune System Problems in Patients with Common Variable Immunodeficiency

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Leniolisib Phosphate
    Spain

  • Study on the Effect of Human Normal Immunoglobulin on Lung Disease in Patients with Primary Antibody Deficiency

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Selective polysaccharide antibody deficiency
    • Primary immunodeficiency syndrome
    Investigated Drugs:
    • Human Normal Immunoglobulin (Iv)
    • Human Normal Immunoglobulin
    The Netherlands

  • Trial of Ataluren for Severe Common Variable Immunodeficiency with Autoimmunity in Patients with LRBA Deficiency

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Ataluren
    Belgium

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!